Search results for btg2

144 hits were found for btg2

# Family MCID Name MIFTS Score
1
P HPT023 Hepatocellular Carcinoma 95 2.449
2
P BRS047 Breast Cancer 97 2.370
3
P BLD134 Bladder Cancer 79 2.297
4
CLR030 Clear Cell Renal Cell Carcinoma 54 2.104
5
P LNG032 Lung Cancer 98 1.944
6
OST159 Osteogenic Sarcoma 66 1.836
7
P PNC035 Pancreatic Cancer 86 1.831
8
c SML038 Small Cell Cancer of the Lung 69 1.819
9
GST040 Gastric Adenocarcinoma 66 1.779
10
ADR040 Adrenal Gland Pheochromocytoma 45 1.616
11
P PHC003 Pheochromocytoma 70 1.616
12
RNL114 Renal Cell Carcinoma, Nonpapillary 79 1.584
13
GLM045 Glioma 62 1.564
14
GLL048 Glial Tumor 52 1.564
15
PNC041 Pancreatic Ductal Adenocarcinoma 51 1.550
16
P LKM062 Leukemia, Acute Lymphoblastic 69 1.519
17
P LRY044 Larynx Cancer 53 1.502
18
P GST053 Gastric Cancer 82 1.464
19
ADN018 Adenoma 58 1.295
20
SQM006 Squamous Cell Carcinoma 59 1.258
21
ORL015 Oral Squamous Cell Carcinoma 43 1.239
22
P ADN016 Adenocarcinoma 63 1.199
23
P LNG064 Lung Cancer Susceptibility 3 70 1.177
24
GLB002 Glioblastoma 67 1.154
25
P KDN017 Kidney Cancer 60 1.079
26
P OLG002 Oligodendroglioma 66 1.050
27
P RTN024 Retinoblastoma 72 1.019
28
END057 Endometrial Cancer 71 1.019
29
c ACT027 Acute Pancreatitis 60 1.019
30
HYP266 Hypoxia 56 1.019
31
CRV035 Cervical Cancer 72 0.985
32
P MDL005 Medulloblastoma 75 0.985
33
P PNC044 Pancreatitis 61 0.985
34
P PTT006 Pituitary Adenoma 55 0.985
35
c TYP009 Type 2 Diabetes Mellitus 92 0.946
36
P BLY001 B-Lymphoblastic Leukemia/lymphoma 52 0.946
37
P BDY004 Body Mass Index Quantitative Trait Locus 11 83 0.899
38
c BDY011 Body Mass Index Quantitative Trait Locus 10 45 0.899
39
c BDY012 Body Mass Index Quantitative Trait Locus 7 43 0.899
40
c BDY010 Body Mass Index Quantitative Trait Locus 4 46 0.899
41
c BDY005 Body Mass Index Quantitative Trait Locus 9 47 0.899
42
c BDY006 Body Mass Index Quantitative Trait Locus 8 43 0.899
43
c BDY015 Body Mass Index Quantitative Trait Locus 12 46 0.899
44
c BDY017 Body Mass Index Quantitative Trait Locus 14 45 0.899
45
c BDY019 Body Mass Index Quantitative Trait Locus 18 47 0.899
46
c BDY020 Body Mass Index Quantitative Trait Locus 19 51 0.899
47
P GRV001 Graves' Disease 54 0.899
48
HYP066 Hyperglycemia 60 0.839
49
c PCH010 Pachyonychia Congenita 3 43 0.826
50
CLN044 Colon Adenoma 44 0.526
51
CLR108 Colorectal Adenoma 63 0.526
52
GLC003 Glucose Intolerance 53 0.506
53
P LYM118 Lymphoma 69 0.506
54
VNH007 Von Hippel-Lindau Syndrome 73 0.505
55
MLT003 Multilocular Clear Cell Renal Cell Carcinoma 32 0.505
56
MLT165 Multilocular Cystic Renal Neoplasm of Low Malignant Potential 28 0.505
57
P EST001 Estrogen-Receptor Positive Breast Cancer 49 0.413
58
P SKN015 Skin Carcinoma 71 0.413
59
P BCL017 B-Cell Lymphoma 57 0.413
60
DFF005 Diffuse Large B-Cell Lymphoma 55 0.386
61
c DNT047 Dentinogenesis Imperfecta Type 2 35 0.386
62
THY029 Thyroid Carcinoma 54 0.358
63
PRS129 Prostatic Hyperplasia, Benign 48 0.326
64
P MYC007 Myocardial Infarction 69 0.326
65
PRS021 Prostatic Adenoma 43 0.326
66
PRS045 Prostatic Hypertrophy 52 0.326
67
LYM133 Lymphoma, Hodgkin, Classic 74 0.292
68
BRN028 Brain Cancer 73 0.292
69
P LKM002 Leukemia 66 0.292
70
EWN003 Ewing Sarcoma 70 0.253
71
SRC014 Sarcoma 64 0.253
72
GRG001 Greig Cephalopolysyndactyly Syndrome 64 0.253
73
LNG039 Lung Squamous Cell Carcinoma 57 0.253
74
CLN015 Colon Adenocarcinoma 64 0.253
75
SPN035 Spindle Cell Sarcoma 51 0.253
76
P NRB001 Neuroblastoma 66 0.253
77
PTT037 Pituitary Tumors 44 0.253
78
c ACT075 Acute Myocardial Infarction 55 0.253
79
MYP106 Myopathy, Myosin Storage, Autosomal Recessive 33 0.206
80
LYM143 Lymphoma, Non-Hodgkin, Familial 79 0.206
81
P PLM037 Pulmonary Hypertension 69 0.206
82
HLX001 Helix Syndrome 47 0.206
83
P ADV001 Advanced Sleep Phase Syndrome 41 0.206
84
P INF037 Inflammatory Bowel Disease 53 0.206
85
BRK010 Burkitt Lymphoma 66 0.206
86
P ATT013 Attention Deficit-Hyperactivity Disorder 66 0.206
87
CRT013 Carotid Stenosis 51 0.206
88
P MYL006 Myeloid Leukemia 60 0.206
89
LNG099 Lung Disease 62 0.206
90
BRN056 Bronchopulmonary Dysplasia 57 0.206
91
TCL028 T-Cell Lymphoblastic Leukemia/lymphoma 46 0.206
92
c LKM005 Leukemia, T-Cell, Chronic 33 0.206
93
P SCH015 Schizophrenia 74 0.146
94
CHR072 Chordoma 57 0.146
95
MYL069 Myeloma, Multiple 77 0.146
96
YMN001 Yemenite Deaf-Blind Hypopigmentation Syndrome 66 0.146
97
c LKM063 Leukemia, Chronic Myeloid 71 0.146
98
ACT119 Acute Promyelocytic Leukemia 62 0.146
99
IMM196 Immunodeficiency 15a 21 0.146
100
NRN005 Neuronal Ceroid-Lipofuscinoses 61 0.146
101
ATS010 Autosomal Recessive Disease 42 0.146
102
SCH074 Schuurs-Hoeijmakers Syndrome 48 0.146
103
CRB004 Cerebral Artery Occlusion 46 0.146
104
RLP008 Relapsed/refractory Diffuse Large B-Cell Lymphoma 35 0.146
105
IMM011 Immunodeficiency-Centromeric Instability-Facial Anomalies Syndrome 52 0.146
106
c HYD046 Hydatidiform Mole, Recurrent, 1 59 0.146
107
P RHM011 Rheumatoid Arthritis 81 0.146
108
EPD052 Epidermolysis Bullosa Simplex Superficialis 17 0.146
109
P CLR023 Colorectal Cancer 100 0.146
110
c CRD186 Ceroid Lipofuscinosis, Neuronal, 3 62 0.146
111
DGR001 Digeorge Syndrome 62 0.146
112
P LKM071 Leukemia, Chronic Lymphocytic 74 0.146
113
P EPL164 Epilepsy 70 0.146
114
STT001 Status Epilepticus 58 0.146
115
LTN029 Latent Autoimmune Diabetes in Adults 38 0.146
116
P BRC006 Brachydactyly 52 0.146
117
CHL068 Cholestasis 61 0.146
118
ISC004 Ischemia 61 0.146
119
THY020 Thyroid Hyalinizing Trabecular Adenoma 19 0.146
120
ACT084 Acute Stress Disorder 53 0.146
121
URM002 Uremia 47 0.146
122
P HYP040 Hypospadias 51 0.146
123
ENT004 Enthesopathy 51 0.146
124
PST028 Post-Traumatic Stress Disorder 59 0.146
125
P MLN008 Melanoma 75 0.146
126
P NRN021 Neuronal Ceroid Lipofuscinosis 64 0.146
127
RCH001 Richter's Syndrome 44 0.146
128
INS001 Insulinoma 59 0.146
129
P CNT005 Central Nervous System Lymphoma 51 0.146
130
RTN003 Retinal Ischemia 48 0.146
131
P TMP001 Temporal Lobe Epilepsy 49 0.146
132
c LKM061 Leukemia, Acute Myeloid 83 0.146
133
c HMP012 Hemophagocytic Lymphohistiocytosis, Familial, 2 47 0.146
134
P CRN300 Coronary Heart Disease 1 73 0.146
135
TCL008 T-Cell Lymphoma 1a 17 0.146
136
P GST044 Gastritis 55 0.146
137
GST010 Gestational Trophoblastic Neoplasm 52 0.146
138
P VSC011 Vasculitis 61 0.146
139
CLP006 Clopidogrel Resistance 44 0.146
140
P CTR002 Cataract 59 0.146
141
PRM226 Primary Central Nervous System Lymphoma 47 0.146
142
PCS003 Pacs1 Syndrome 16 0.146
143
END086 End Stage Renal Disease 54 0.146
144
P DBT009 Diabetes Mellitus 67 0.146
Content
Loading form....